Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Liver International Année : 2022

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease

Fichier non déposé

Dates et versions

hal-03789509 , version 1 (27-09-2022)

Identifiants

Citer

Nga Nguyen, Agnès Rode, Hervé Trillaud, Christophe Aubé, Anne Frédérique Manichon, et al.. Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease. Liver International, 2022, 42 (4), pp.905-917. ⟨10.1111/liv.15129⟩. ⟨hal-03789509⟩
30 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More